Complications and outcomes of primary phacotrabeculectomy with mitomycin C in a multi-ethnic asian population

David Z Chen1, Victor Koh2, Chelvin Sng2

  • 1Department of Ophthalmology, National University Health System, Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Plos One
|March 17, 2015
PubMed
Abstract

Insights

Phacotrabeculectomy with Mitomycin C (MMC) can cause complications like hypotony, hyphema, and shallow anterior chamber in glaucoma patients. Early hypotony is a significant risk factor for surgical failure.

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery
  • Surgical Complications

Background:

  • Phacotrabeculectomy with intraoperative Mitomycin C (MMC) is a common procedure for glaucoma.
  • Understanding postoperative complications is crucial for managing surgical outcomes.

Purpose of the Study:

  • To assess the incidence of intraoperative and postoperative complications following primary phacotrabeculectomy with MMC.
  • To evaluate the impact of these complications on surgical success in primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG) patients.
  • To identify risk factors for surgical failure related to postoperative complications.

Main Methods:

  • Retrospective review of 160 patients (105 POAG, 55 PACG) who underwent primary phacotrabeculectomy with MMC.
  • Data collection included patient demographics, ocular characteristics, and postoperative complications (hypotony, shallow anterior chamber, hyphema).
  • Follow-up extended up to three years to assess surgical outcomes and complication effects.

Main Results:

  • The most common complications were hypotony (25.6%), hyphema (10.0%), and shallow anterior chamber (10.0%).
  • 77% of complications occurred within the first postoperative month.
  • Early hypotony (within 30 days) was an independent risk factor for surgical failure (HR 5.1, p=0.01).
  • Hypotony combined with other complications also increased the risk of surgical failure (p<0.02).

Conclusions:

  • Hypotony, hyphema, and shallow anterior chamber are the most frequent postoperative complications after phacotrabeculectomy with MMC.
  • The majority of these complications are transient and resolve spontaneously.
  • Early postoperative hypotony is a critical predictor of long-term surgical failure in glaucoma patients.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K